- Home
- ELF vs PCVX Comparison
ELF vs PCVX Comparison
Compare ELF & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELF
- PCVX
- Stock Information
- Founded
- ELF 2004
- PCVX 2013
- Country
- ELF United States
- PCVX United States
- Employees
- ELF N/A
- PCVX N/A
- Industry
- ELF Package Goods/Cosmetics
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- ELF Consumer Discretionary
- PCVX Health Care
- Exchange
- ELF Nasdaq
- PCVX Nasdaq
- Market Cap
- ELF 6.9B
- PCVX 4.4B
- IPO Year
- ELF 2016
- PCVX 2020
- Fundamental
- Price
- ELF $131.25
- PCVX $33.25
- Analyst Decision
- ELF Buy
- PCVX Strong Buy
- Analyst Count
- ELF 16
- PCVX 10
- Target Price
- ELF $119.19
- PCVX $136.50
- AVG Volume (30 Days)
- ELF 1.9M
- PCVX 1.5M
- Earning Date
- ELF 08-07-2025
- PCVX 08-05-2025
- Dividend Yield
- ELF N/A
- PCVX N/A
- EPS Growth
- ELF N/A
- PCVX N/A
- EPS
- ELF 1.92
- PCVX N/A
- Revenue
- ELF $1,313,517,000.00
- PCVX N/A
- Revenue This Year
- ELF $22.42
- PCVX N/A
- Revenue Next Year
- ELF $15.80
- PCVX N/A
- P/E Ratio
- ELF $68.22
- PCVX N/A
- Revenue Growth
- ELF 28.28
- PCVX N/A
- 52 Week Low
- ELF $49.40
- PCVX $27.66
- 52 Week High
- ELF $219.77
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- ELF 73.77
- PCVX 45.61
- Support Level
- ELF $123.34
- PCVX $32.00
- Resistance Level
- ELF $127.06
- PCVX $34.63
- Average True Range (ATR)
- ELF 5.16
- PCVX 1.33
- MACD
- ELF -1.14
- PCVX -0.06
- Stochastic Oscillator
- ELF 91.32
- PCVX 33.67
About ELF e.l.f. Beauty Inc.
e.l.f. Beauty Inc is a multi-brand beauty company that offers inclusive, accessible, clean, vegan, and cruelty-free cosmetics and skin care products. The Company's mission is to make beauty accessible to every eye, lip, face, and skin concern. The company offers cosmetic accessories for women, which include eyeliner, mascara, false eyelashes, lipstick, foundation for the face, moisturizer, cleanser, and other tools through its stores and e-commerce channels.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.